143 related articles for article (PubMed ID: 33408315)
1. Dose-Dependent Inhibitory Effect of Rosuvastatin in Japanese Patients with Acute Myocardial Infarction on Serum Concentration of Matrix Metalloproteinases-INVITATION Trial.
Shirakawa T; Fujisue K; Nakamura S; Yamamoto N; Oshima S; Matsumura T; Tsunoda R; Hirai N; Koide S; Tayama S; Kikuta K; Hirose T; Maruyama H; Fujimoto K; Kajiwara I; Sakamoto T; Nakao K; Sakaino N; Nagayoshi Y; Hokamaki J; Shimomura H; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
J Atheroscler Thromb; 2022 Feb; 29(2):229-241. PubMed ID: 33408315
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases - INVITATION trial.
Fujisue K; Shirakawa T; Nakamura S; Yamamoto N; Oshima S; Matsumura T; Tsunoda R; Hirai N; Tayama S; Nakamura N; Hirose T; Maruyama H; Fujimoto K; Kajiwara I; Sakamoto T; Nakao K; Sakaino N; Hokimoto S; Nagayoshi Y; Hokamaki J; Shimomura H; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Ogawa H; Tsujita K;
J Cardiol; 2018 Oct; 72(4):350-355. PubMed ID: 29735336
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins.
Altaf A; Qu P; Zhao Y; Wang H; Lou D; Niu N
Coron Artery Dis; 2015 Aug; 26(5):409-21. PubMed ID: 25946654
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
Nakaya R; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Yamazaki T; Ueda T; Lee JD
Int J Cardiol; 2005 Oct; 105(1):67-73. PubMed ID: 16207547
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
Eckart RE; Uyehara CF; Shry EA; Furgerson JL; Krasuski RA
J Interv Cardiol; 2004 Feb; 17(1):27-31. PubMed ID: 15009768
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI).
Martins KB; Mattos LA; Sousa AG; Sousa JE; Abzaid A; Feres F; de Ribamar JC; Staico R; Costa RA; Chaves AJ
J Interv Cardiol; 2015 Aug; 28(4):339-47. PubMed ID: 26086603
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty.
Kuliczkowski W; Urbaniak J; Hallén J; Woźniak M; Poloński L; Mysiak A; Atar D; Zembala M; Serebruany V
Kardiol Pol; 2013; 71(5):453-63. PubMed ID: 23788085
[TBL] [Abstract][Full Text] [Related]
12. High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
Ueland T; Butt N; Lekva T; Ørn S; Manhenke C; Aukrust P; Larsen AI
Int J Cardiol; 2024 Jul; 406():132035. PubMed ID: 38604450
[TBL] [Abstract][Full Text] [Related]
13. Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction.
Liu ZJ; Hu GP; Fei MY; Yin Z; Shi QX; Sun F
Chin Med Sci J; 2018 Jun; 33(2):84-90. PubMed ID: 29976277
[TBL] [Abstract][Full Text] [Related]
14. Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease.
Wang X; Zhao X; Li L; Yao H; Jiang Y; Zhang J
Heart Lung Circ; 2016 May; 25(5):459-65. PubMed ID: 26687339
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction.
Tunçez A; Altunkeser BB; Öztürk B; Ateş MS; Tezcan H; Aydoğan C; Kırık EC; Yalçın U; Aygül N; Demir K; Akyürek F
Anatol J Cardiol; 2019 Nov; 22(5):240-249. PubMed ID: 31674929
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.
Šímová J; Škvor J; Slovák D; Mazura I; Zvárová J
Folia Biol (Praha); 2013; 59(5):181-7. PubMed ID: 24280140
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).
Ko YG; Won H; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Bae JH; Lee S; Lim DS; Jang Y
Am J Cardiol; 2014 Jul; 114(1):29-35. PubMed ID: 24831577
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
Otake H; Sugizaki Y; Toba T; Nagano Y; Tsukiyama Y; Yanaka KI; Yamamoto H; Nagasawa A; Onishi H; Takeshige R; Nakano S; Matsuoka Y; Tanimura K; Kawamori H; Shinke T; Hirata KI
J Cardiol; 2019 Mar; 73(3):228-232. PubMed ID: 30579806
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
[TBL] [Abstract][Full Text] [Related]
20. Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9.
Zhou L; Kou DQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):297-302. PubMed ID: 30657570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
